Thermo Fisher Scientific sees Q2 revenue boost from COVID-19 testing

LabPulse.com staff writers
Jul 5, 2020
2019 11 08 00 07 5193 Thermo Fisher Amp 2019 400

Thermo Fisher Scientific saw a 10% increase in revenue in its second quarter (end-June 27).

The growth was prompted by global sales of reverse transcription polymerase chain reaction (RT-PCR) tests and other products supporting the response to the COVID-19 pandemic, according to the firm; these sales contributed more than $1.4 billion in revenue.

The company plans to release its full results for the quarter on July 22.

Latest in PCR
Roche Aacc 2019 Social
Roche launches diagnostic test for 12 respiratory viruses
September 26, 2024
Body composition in patients treated with Ozempic
Sponsored
Body composition in patients treated with Ozempic
September 20, 2024
Research Money Social
Seegene, Springer Nature launch PCR innovation program
September 3, 2024
Monkeypox Virus Social
CDC prioritizes mpox specimens for testing laboratories
August 28, 2024
Related Stories
Business Economics Pie Chart Social
Financial Results
Roche, Thermo Fisher sales drop on diagnostic testing decline in Q1
2020 01 09 22 46 7361 Business Deal Corporate 400
Financial Results
Thermo Fisher's Q4 overall revenues rise, diagnostics fall
2020 05 07 22 15 9104 Thermo Fisher Scientific 400
Infectious
Thermo Fisher's Q3 earnings boosted by COVID-19 sales
Body composition in patients treated with Ozempic
Sponsor Content
Body composition in patients treated with Ozempic
More in PCR
Roche launches diagnostic test for 12 respiratory viruses
By LabPulse.com staff writers
Roche Diagnostics has launched its first test using its new high-throughput technology that enables users of Roche's Cobas analyzers to simultaneously test for 12 respiratory viruses.
September 26, 2024
Roche Aacc 2019 Social
CDC adds commercial lab contracts for infectious disease, bird flu testing
By Liz Carey
Clinical laboratories incentivized to develop diagnostic tests earlier.
September 17, 2024
Colorized transmission electron micrograph of avian influenza A H5N1 virus particles shown in yellow.
Seegene, Springer Nature launch PCR innovation program
By LabPulse.com staff writers
Molecular diagnostics firm Seegene and Springer Nature have launched a new project for the development of diagnostic assays, as part of their ongoing strategic partnership.
September 3, 2024
Research Money Social
CDC prioritizes mpox specimens for testing laboratories
By LabPulse.com staff writers
The CDC recommended that all laboratories performing mpox testing send certain types of clinical specimens to a laboratory that can perform clade-specific testing as quickly as possible.
August 28, 2024
Monkeypox Virus Social
Seegene develops two RUO mpox assays
By LabPulse.com staff writers
Seegene has developed two polymerase chain reaction (PCR) test assays for mpox research testing.
August 26, 2024
Monkeypox Virus Social
FDA greenlights BioMérieux's mini respiratory, sore throat panel for POC testing
By LabPulse.com staff writers
BioMérieux received special 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Biofire Spotfire Respiratory/Sore Throat (R/ST) Panel Mini respiratory viral and bacterial testing device designed for point-of-care (POC) testing.
June 28, 2024
Business Regulation Graphic Social Resized
Co-Diagnostics submits 510(k) applications for platform, OTC COVID-19 test
By LabPulse.com staff writers
Molecular diagnostics firm Co-Diagnostics submitted its first U.S. Food and Drug Administration application for 510(k) clearance for its Co-Dx PCR Pro instrument, along with the Co-Dx PCR COVID-19 Test for over-the-counter (OTC) use.
June 17, 2024
Fda Button Social
Qiagen gets FDA clearance for respiratory syndromic testing panel
By LabPulse.com staff writers
Qiagen announced that it has received U.S. Food and Drug Administration (FDA) clearance for its QIAstat-Dx respiratory syndromic testing panel for clinical use.
May 14, 2024
Fda Button Social
Qiagen partners with FBI on forensics assay
By LabPulse.com staff writers
Qiagen has announced a collaboration with the FBI to develop a new assay to improve DNA quantification for use in forensics and human identification.
May 8, 2024
Lab Pcr Tubes Dna Social
AMDI receives $5.2M in RADx Tech funding for PCR viral testing system
By LabPulse.com staff writers
Autonomous Medical Devices Incorporated (AMDI) has received a U.S. National Institutes of Health (NIH) RADx Tech award of up to $5.2 million to finalize its rapid point-of-care viral testing system.
March 4, 2024
Money Bag Grant Award Social
Thermo Fisher launches new instrument, kit for respiratory testing
By LabPulse.com staff writers
Thermo Fisher Scientific has launched a nucleic acid purification instrument and kit for automated viral and bacterial respiratory testing.
December 11, 2023
Influenza Virus Social
Researchers develop technique for onsite detection of SARS-CoV-2
By LabPulse.com staff writers
Researchers have developed a portable laboratory device for rapid onsite detection of SARS-CoV-2 RNA which holds promise for scenarios in which there is no or limited access to testing laboratories.
October 10, 2023
Coronavirus Covid Blue Social
Page 1 of 23
Next Page